HNNS L18 - Sedatives And Hypnotics Flashcards
Diazepam
Benzodiazepine Both sedative and hypnotic Low dose for acute panic anxiety Fast onset and offset Long acting
Chlordiazepoxide
Benzodiazepine (sedative)
Low dose for chronic anxiety states
Long-acting
Alprazolam
Benzodiazepine (sedative)
Low dose for anxiolytic-antidepressant effect
Intermediate-acting
Lorazepam
Benzodiazepine (sedative)
Intermediate-acting
Clonazepam
Benzodiazepine (sedative)
Fast onset
Long-acting
Flurazepam
Benzodiazepine (hypnotics)
Long acting
High dose for sedative + hypnotic effects
Temazepam
Benzodiazepine (hypnotics)
Intermediate acting
High dose for sedative + hypnotic effects
Triazolam
Benzodiazepine (hypnotics)
Fast onset
Short acting
High dose for sedative + hypnotic effects
Flumazenil
Competitive antagonist of benzodiazepines (for overdose of BDZs and Zolpidem(?), IV)
MoA of Benzodiazepines
Activate GABA-A receptors by binding to BZ1 and BZ2 (between alpha and gamma subunits)
Increase frequency of Cl channel opening
Hyperpolarization
Increase inhibitory signals
Effects of Benzodiazepines
Anxiolytic
Induction of sleep
Reduce muscle tone and co-ordination
Anti-convulsant
Adverse effects of benzodiazepines
- Drowsiness, confusion (most common)
- Decrease in motor coordination
- Decrease in psychomotor performances
- Anterograde amnesia
- Respiratory depression and death if taken with ethanol
- Dependence
- Tolerance
Flumazenil: MoA, Adverse effects
Competitive antagonist of BDZs at GABA-A receptor
- reversal of BDZ overdose (IV)
- Dizziness, confusion, nausea
- Agitation
- Seizure
- (Withdrawal)
Barbiturates: MoA
[1] Potentiate GABA action on Cl- entry into the neuron by prolonging the duration of Cl- channel openings
[2] Block excitatory glutamate AMPA receptors –> decreased glutamate-induced excitation
[3] Anaesthetic (high) concentrations of pentobarbital blocks high-frequency Na+ channels –> decrease neuronal activity
Barbiturates: adverse effects / disadvantages (X8)
- Drowsiness, decreased motor control
- Induction of hepatic CYP450, decrease effect of other drugs metabolized by these enzymes
- High degree of tolerance and dependence + very severe withdrawal symptoms
- High dose: respiratory depression, coma
- Low therapeutic index
- Increase in heme synthesis: contraindicated in porphyrias
- Sleep disturbance
- Used as hypnotics: suppress REM sleep more than other stages
Metabolism of BDZs
Conjugation with glucuronide
Urinary excretion
Midazolam
BDZ (short acting, half life <5 hours)
Long-acting BDZs
Chlordiazepoxide
Clonazepam*
Diazepam (Valium)*
Flurazepam